ECT Reprograms Adult Neurons into a Youthful State

Electroconvulsive therapy (ECT)-like stimulation induces a durable state of cellular dematuration and epigenetic nuclear reprogramming in mature, post-mitotic neurons.

Summary: Researchers engineered a highly specialized patterned stimulation protocol called REPOPS (Repeated Electroconvulsive-like Patterned Optical/Electrical Stimulation) in murine models to precisely mirror the neural activation patterns of ECT. The empirical data unmasked a stunning structural transformation: intensive ECT-like stimulation coaxes fully mature, non-dividing adult neurons to undergo an active process of cellular dematuration. By entering a state of nuclear reprogramming driven unexpectedly by the cell-cycle protein Cyclin B, mature neurons fundamentally reshape their identity, winding back their genetic clocks to resemble highly plastic, early postnatal developmental states.

Key Facts The Cellular Dematuration Framework: Genome-wide transcriptomic profiling unmasked that REPOPS forces mature, fully differentiated adult neurons to suppress their adult genetic markers. Instead, they reactivate gene expression blueprints that match early postnatal development. Widespread genome-wide chromatin mapping confirmed long-lasting structural changes in chromatin accessibility, proving this youthful state is epigentically locked in place for over a month.

Unexpected Post-Mitotic Cell Cycle Re-entry: The most jaw-dropping molecular discovery was that adult neurons, cells that are strictly post-mitotic and can never divide again, suddenly expressed gene networks typically reserved exclusively for the G2/M division phase of proliferating cells. The neurons displayed clear physical hallmarks of mitosis, including widespread histone phosphorylation, the breakdown of the nuclear lamina protective skin, and pronounced chromatin condensation. Cyclin B Isolated as the Molecular Driver: To prove this cell-cycle activation was driving the structural shift rather than acting as a random byproduct, Miyakawa’s lab deployed targeted genome-editing technology.

Mice engineered to lack Cyclin B (the core molecular key required to cross the G2/M phase boundary) exhibited a total failure of nuclear reprogramming and showed zero behavioral improvements following stimulation, identifying Cyclin B as the absolute gatekeeper of ECT efficacy. The “Intermediate State” of Heightened Plasticity: Calcium-flux live imaging in actively behaving mice revealed that REPOPS does not simply act as an on/off switch for neural circuits. Instead, it coaxes the brain into a unique “intermediate state” of intense plasticity.

The network completely shifted how it encoded information, selectively suppressing spatial coding maps while heavily boosting speed-related navigation tracking for over two weeks. Human Validation in the Dentate Gyrus: Transitioning from mice to humans, the team’s reanalysis of postmortem brain tissue from deceased patients with major depression revealed an identical biological footprint. Individuals who had undergone ECT treatments prior to their passing displayed the exact same immature-like gene expression patterns within the dentate gyrus (the primary gateway of the hippocampus) compared to non-ECT patients, confirming human translation.

A Double-Edged Sword for Neurology: Professor Miyakawa emphasizes that this newly uncovered intermediate state is a powerful, highly flexible biological tool. While this extreme boost in structural plasticity is precisely what allows an injured brain to break free from severe depression, the team warns that if the exact same nuclear reprogramming occurs under incorrect or overly aggressive conditions (such as advanced neurodegeneration or epilepsy), it could spin out of control and drive severe pathology.